CABALETTA BIO, INC. Increase (Decrease) in Other Operating Assets
CABALETTA BIO, INC. (CABA) reported Increase (Decrease) in Other Operating Assets of $1.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-13
- CABALETTA BIO, INC. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $934.00K, a 602.26% increase year-over-year.
- CABALETTA BIO, INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $114.00K, a 50.00% increase year-over-year.
- CABALETTA BIO, INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $1.55M.
- CABALETTA BIO, INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $1.10M, a 380.43% increase year-over-year.
- CABALETTA BIO, INC. increase (decrease) in other operating assets for fiscal 2025 was $2.87M, a 390.75% increase from fiscal 2024.
- CABALETTA BIO, INC. increase (decrease) in other operating assets for fiscal 2024 was $584.00K, a 48.95% decline from fiscal 2023.
- CABALETTA BIO, INC. increase (decrease) in other operating assets for fiscal 2023 was $1.14M, a 450.00% increase from fiscal 2022.
- CABALETTA BIO, INC. increase (decrease) in other operating assets for fiscal 2022 was $208.00K, a 258.62% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $934.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.05M 10-Q · filed 2026-08-13 | $2.60M derived: sum of 3 quarters · filed 2026-08-13 | $3.71M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $114.00K 10-Q · filed 2026-05-14 | $1.67M derived: sum of 2 quarters · filed 2026-05-14 | $2.77M derived: sum of 3 quarters · filed 2026-05-14 | $2.90M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $2.66M derived: sum of 2 quarters · filed 2026-03-23 | $2.79M derived: sum of 3 quarters · filed 2026-08-13 | $2.87M 10-K · filed 2026-03-23 |
| 2025-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.24M derived: sum of 2 quarters · filed 2026-08-13 | $1.31M 10-Q · filed 2025-11-10 | $1.13M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $209.00K 10-Q · filed 2026-08-13 | $20.00K derived: sum of 3 quarters · filed 2026-08-13 | $250.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $76.00K 10-Q · filed 2026-05-14 | -$113.00K derived: sum of 2 quarters · filed 2026-05-14 | $117.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $41.00K derived: sum of 2 quarters · filed 2026-03-23 | -$75.00K derived: sum of 3 quarters · filed 2026-03-23 | $584.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $114.00K derived: sum of 2 quarters · filed 2025-11-10 | $773.00K 10-Q · filed 2025-11-10 | $1.50M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $543.00K 10-Q · filed 2025-08-07 | $1.27M derived: sum of 3 quarters · filed 2025-08-07 | $1.57M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $659.00K 10-Q · filed 2025-05-15 | $1.38M derived: sum of 2 quarters · filed 2025-05-15 | $1.68M derived: sum of 3 quarters · filed 2025-05-15 | $1.79M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $724.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.02M derived: sum of 2 quarters · filed 2025-03-31 | $1.13M derived: sum of 3 quarters · filed 2025-03-31 | $1.14M 10-K · filed 2025-03-31 |
| 2023-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $404.00K derived: sum of 2 quarters · filed 2024-11-14 | $420.00K 10-Q · filed 2024-11-14 | $296.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $120.00K 10-Q · filed 2024-08-08 | -$4.00K derived: sum of 3 quarters · filed 2024-08-08 | -$280.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $16.00K 10-Q · filed 2024-05-15 | -$108.00K derived: sum of 2 quarters · filed 2024-05-15 | -$384.00K derived: sum of 3 quarters · filed 2024-05-15 | -$404.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$400.00K derived: sum of 2 quarters · filed 2024-03-21 | -$420.00K derived: sum of 3 quarters · filed 2024-03-21 | $208.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | -$276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$296.00K derived: sum of 2 quarters · filed 2023-11-09 | $332.00K 10-Q · filed 2023-11-09 | $365.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $608.00K 10-Q · filed 2023-08-10 | $641.00K derived: sum of 3 quarters · filed 2023-08-10 | $647.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $628.00K 10-Q · filed 2023-05-11 | $661.00K derived: sum of 2 quarters · filed 2023-05-11 | $667.00K derived: sum of 3 quarters · filed 2023-05-11 | $685.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $39.00K derived: sum of 2 quarters · filed 2023-03-16 | $57.00K derived: sum of 3 quarters · filed 2023-03-16 | $58.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $24.00K derived: sum of 2 quarters · filed 2022-11-10 | $25.00K 10-Q · filed 2022-11-10 | $85.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $19.00K 10-Q · filed 2022-08-11 | $79.00K derived: sum of 3 quarters · filed 2022-08-11 | $80.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-12 | $61.00K derived: sum of 2 quarters · filed 2022-05-12 | $62.00K derived: sum of 3 quarters · filed 2022-05-12 | $195.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $61.00K derived: sum of 2 quarters · filed 2022-03-17 | $194.00K derived: sum of 3 quarters · filed 2022-03-17 | $198.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $134.00K derived: sum of 2 quarters · filed 2021-11-01 | $138.00K 10-Q · filed 2021-11-01 | $148.00K derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $137.00K 10-Q · filed 2021-08-05 | $147.00K derived: sum of 3 quarters · filed 2021-08-05 | $149.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $4.00K 10-Q · filed 2021-05-03 | $14.00K derived: sum of 2 quarters · filed 2021-05-03 | $16.00K derived: sum of 3 quarters · filed 2021-05-03 | $77.00K derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $12.00K derived: sum of 2 quarters · filed 2021-03-16 | $73.00K derived: sum of 3 quarters · filed 2021-03-16 | $101.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $63.00K derived: sum of 2 quarters · filed 2020-11-10 | $91.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $89.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $28.00K 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |